![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Silverberg, Jonathan I.; Guttman-Yassky, Emma; Agner, Tove; Bissonnette, Robert; Cohen, David E.; Simpson, Eric; Wollenberg, Andreas und Thyssen, Jacob P.
(2021):
Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council.
In: Dermatitis, Bd. 32, Nr. 5: S. 319-326
Silverberg, Jonathan I.; Guttman-Yassky, Emma; Gooderham, Melinda; Worm, Margitta; Rippon, Stephanie; O'Quinn, Sean; Merwe, Rene van der; Kragh, Nana; Kurbasic, Azra und Wollenberg, Andreas
(2021):
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis A phase 2b randomized study.
In: Annals of Allergy Asthma & Immunology, Bd. 126, Nr. 5: S. 576-583
Guttman-Yassky, Emma; Hanifin, Jon M.; Boguniewicz, Mark; Wollenberg, Andreas; Bissonnette, Robert; Purohit, Vivek; Kilty, Iain; Tallman, Anna M. und Zielinski, Michael A.
(2019):
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.
In: Experimental Dermatology, Bd. 28, Nr. 1: S. 3-10
Eyerich, Kilian; Brown, Sara J.; White, Bethany E. Perez; Tanaka, Reiko J.; Bissonette, Robert; Dhar, Sandipan; Bieber, Thomas; Hijnen, Dirk J.; Guttman-Yassky, Emma; Irvine, Alan; Thyssen, Jacob P.; Vestergaard, Christian; Werfel, Thomas; Wollenberg, Andreas; Paller, Amy S. und Reynolds, Nick J.
(2019):
Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council.
In: Journal of Allergy and Clinical Immunology, Bd. 143, Nr. 1: S. 36-45
Wollenberg, Andreas; Howell, Michael D.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Kell, Christopher; Ranade, Koustubh; Moate, Rachel und van der Merwe, Rene
(2019):
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.
In: Journal of Allergy and Clinical Immunology, Bd. 143, Nr. 1: S. 135-141
Simpson, Eric L.; Bruin-Weller, Marjolein; Flohr, Carsten; Ardern-Jones, Michael R.; Barbarot, Sebastien; Deleuran, Mette; Bieber, Thomas; Vestergaard, Christian; Brown, Sara J.; Cork, Michael J.; Drucker, Aaron M.; Eichenfield, Lawrence F.; Fölster-Holst, Regina; Guttman-Yassky, Emma; Nosbaum, Audrey; Reynolds, Nick J.; Silverberg, Jonathan I.; Schmitt, Jochen; Seyger, Marieke M. B.; Spuls, Phyllis I.; Stalder, Jean-Francois; Su, John C.; Takaoka, Roberto; Traidl-Hoffmann, Claudia; Thyssen, Jacob P.; Schaft, Jorien van der; Wollenberg, Andreas; Irvine, Alan D. und Paller, Amy S.
(2017):
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
In: Journal of the American Academy of Dermatology, Bd. 77, Nr. 4: S. 623-633
Wollenberg, Andreas; Howell, Michael D.; Guttman-Yassky, Emma; Silverberg, Jonathan I.; Birrell, Claire; Kell, Chris; Dawson, Michelle und Merwe, Rene van der
(2017):
A phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD).
In: Journal of the American Academy of Dermatology, Bd. 76, Nr. 6:
AB20-AB20
Werfel, Thomas; Allam, Jean-Pierre; Biedermann, Tilo; Eyerich, Kilian; Gilles, Stefanie; Guttman-Yassky, Emma; Hoetzenecker, Wolfram; Knol, Edward; Simon, Hans-Uwe; Wollenberg, Andreas; Bieber, Thomas; Lauener, Roger; Schmid-Grendelmeier, Peter; Traidl-Hoffmann, Claudia und Akdis, Cezmi A.
(2016):
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
In: Journal of Allergy and Clinical Immunology, Bd. 138, Nr. 2: S. 336-349